MyChesCo on MSN2h
Cabaletta Bio to Present Pioneering Clinical Data on Rese-cel at Major Scientific Conferences
Cabaletta Bio, Inc. (Nasdaq: CABA) announced plans to showcase updated clinical data on its investigational CD19-CAR T cell therapy, resecabtagene autoleucel (rese-cel), during two prominent ...
lupus.bmj7h
Rare and common single nucleotide variants in childhood-onset systemic lupus erythematosus
Background SLE is a systemic autoimmune disease with a large number of common risk gene variants, but several rare gene ...
dermatologyadvisor7h
Patients With CLE With Certain Characteristics Have Lower Treatment Response
Patients with CLE who have specific patient characteristics may have lower treatment response than patients who do not have these characteristics.